ORIGINAL RESEARCH article

Front. Vet. Sci.

Sec. Veterinary Infectious Diseases

Volume 12 - 2025 | doi: 10.3389/fvets.2025.1552230

Commercially available antiseptics show high in vitro effectivity against pathogens most commonly associated with canine and feline infectious keratitis

Provisionally accepted
Hinrich  Tönjes WolffHinrich Tönjes Wolff1*Ana  Cristina PirothAna Cristina Piroth1Hilke  OltmannsHilke Oltmanns2Jessica  MeißnerJessica Meißner2Jutta  VerspohlJutta Verspohl3Holger  Andreas VolkHolger Andreas Volk1Claudia  BusseClaudia Busse1*
  • 1Small Animal Clinic, University of Veterinary Medicine Hannover, Hanover, Germany
  • 2Department of Pharmacology, Toxicology and Pharmacy, University of Veterinary Medicine Hannover, Hanover, Germany
  • 3Institute for Microbiology, University of Veterinary Medicine Hannover, Hanover, Germany

The final, formatted version of the article will be published soon.

Purpose: To determine the minimal bactericidal concentration (MBC) of polyhexanide (PHMB), povidone-iodine (PVP-I), N-acetylcysteine (NAC) and hypochlorous acid (HOCl) for bacterial species commonly found in canine and feline infectious keratitis.Methods: MBCs for clinical isolates of Staphylococcus (S.) pseudintermedius (n = 11), including 3 methicillin-resistant strains, Pseudomonas (P. ) aeruginosa (n = 8) and Streptococcus (Str.) canis (n = 11), including the corresponding control strains, were examined.All testing substances were serially diluted in phosphate-buffered saline (PBS) and cationadjusted Mueller-Hinton-Broth (CAMHB) and inoculated with the bacterial suspension for 10 minutes. Afterwards a neutralisation with Dey-Engley neutralising broth was performed, followed by plating onto Columbia sheep-blood-agar. After incubation, plates were visually examined for bacterial growth. Tests were carried out in triplicate.Results: MBCs in PBS for polyhexanide ranged from 0.8 -1.6 mg/l for S. pseudintermedius and from 1.6 -3.2 mg/l for P. aeruginosa and Str. canis. For povidone-iodine MBCs in PBS were observed at concentrations between 8 -32 mg/l for S. pseudintermedius and P. aeruginosa and between 8 -16 mg/l for Str. canis. MBCs in PBS for NAC were recorded at 6400 -12800 mg/l for S. pseudintermedius, whereas those for P. aeruginosa and Str. canis ranged from 3200 -6400 mg/l. Results for HOCl in PBS ranged from 0.4 -1.6 mg/l for S. pseudintermedius and from 0.4 -0.8 mg/l for P. aeruginosa and Str. canis.MBCs in CAMHB for polyhexanide were found in the range between 3.2 -> 12.8 mg/l, those for povidone-iodine between 6400 -> 12800 mg/l and for NAC from 6400 -> 12800 mg/l, across the tested species. When dissolved in CAMHB no antimicrobial effect could be observed for HOCl in concentrations up to 137.5 mg/l.All tested substances had an in vitro bactericidal effect against all three bacterial species with MBCs below known tolerated ocular concentrations when dissolved in PBS. Especially povidone-iodine and hypochlorous acid showed a marked reduction in their in vitro efficacy in the presence of protein. Nevertheless, our results provide a promising outlook on alternatives or adjuvants to antibiotics in ophthalmology in line with the One Health approach.

Keywords: Bacterial keratitis, antibiotic resistance, One Health, Polyhexanide, povidoneiodine, N-acetylcysteine, Hypochlorous Acid

Received: 27 Dec 2024; Accepted: 29 Apr 2025.

Copyright: © 2025 Wolff, Piroth, Oltmanns, Meißner, Verspohl, Volk and Busse. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Hinrich Tönjes Wolff, Small Animal Clinic, University of Veterinary Medicine Hannover, Hanover, Germany
Claudia Busse, Small Animal Clinic, University of Veterinary Medicine Hannover, Hanover, Germany

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.